Epistaxis, commonly encountered in the Otolaryngology practice, refers to bleeding that occurs as a result of vascular pathologies and coagulation disorders. It can develop due to traumatic, iatrogenic, or spontaneous etiologies. In our study, we aim to retrospectively examine the epistaxis patients treated in our clinic to investigate the etiology causing epistaxis, associated diseases, and the use of anticoagulants-antiplatelets. Additionally, we plan to evaluate hemogram and coagulation parameters. The study included patients diagnosed with epistaxis and admitted for treatment at Samsun Education and Research Hospital ENT Clinic between 2019 and 2022. A retrospective analysis of the patients' medical records was conducted to gather data on demographic characteristics, comorbidities, medications used regularly, laboratory values, and clinical findings. A total of 130 patients were included in the study. No statistically significant difference was observed between the location of the bleeding focus and gender, presence of hypertension, use of antihypertensive medication, or anticoagulant use. When comparing patients with and without antiplatelet-anticoagulant use, a significantly longer nasal packing duration was found in patients who used these medications. In terms of the need for electrocauterization, statistically significant higher intervention rates were observed in patients who did not use anticoagulant medication. Our study identified a higher rate of surgical intervention in hospitalized epistaxis patients, potentially due to the inclusion of more severe cases requiring specialized care. Further research is needed to investigate the factors influencing the need for surgical management and to develop appropriate guidelines for the management of different severities of epistaxis.
epistaxis anticoagulant drug nasal packing electrocauterization
Birincil Dil | İngilizce |
---|---|
Konular | Kulak Burun Boğaz |
Bölüm | Research Article |
Yazarlar | |
Erken Görünüm Tarihi | 6 Ekim 2023 |
Yayımlanma Tarihi | 30 Eylül 2023 |
Gönderilme Tarihi | 16 Haziran 2023 |
Kabul Tarihi | 5 Eylül 2023 |
Yayımlandığı Sayı | Yıl 2023 Cilt: 40 Sayı: 3 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.